Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Graverand-Gastineau MPHL et al. - The development of symptom modifying OA drug is exploding with a plethora of pain pathways being pursued and multiple candidates in advanced stages of clinical development. Structure modification in OA remains complex with significant development challenges.

Today in Rheumatology...keeping you current

Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample
Rheumatology International, 12/16/09

Familial Mediterranean Fever in Ashkenazi Jews: The Mild End of the Clinical Spectrum
Journal of Rheumatology, 12/16/09

Predictors of Damage and Survival in Patients with Wegener's Granulomatosis: Analysis of 50 Patients
Journal of Rheumatology, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address